Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22291101 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)
Condition: Shingles
Interventions: Biological: Zoster Vaccine, Live (Zostavax™);   Biological: Comparator: Placebo

Study has passed its completion date and status has not been verified in more than two years.